Assenagon Asset Management S.A. Neogenomics Inc Transaction History

Assenagon Asset Management S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	BUY	$7.06 - $13.97 $25.1 Million - $49.6 Million	3,551,602 Added 5912.24%	3,611,674 $29.4 Million
Q1 2022 Apr 25, 2022	BUY	$12.15 - $35.28 $729,874 - $2.12 Million	60,072 New	60,072 $730,000
Q4 2021 Feb 01, 2022	SELL	$30.49 - $48.49 $152,389 - $242,353	-4,998 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$41.66 - $52.52 $208,216 - $262,494	4,998 New	4,998 $241,000
Q4 2020 Feb 01, 2021	SELL	$36.08 - $56.47 $1.05 Million - $1.65 Million	-29,143 Closed	0 $0
Q3 2020 Oct 07, 2020	BUY	$33.26 - $40.48 $969,296 - $1.18 Million	29,143 New	29,143 $1.08 Million
Q1 2019 Apr 26, 2019	SELL	$12.14 - $20.46 $341,886 - $576,194	-28,162 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$11.24 - $18.5 $316,540 - $520,997	28,162 New	28,162 $355,000

294

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.83B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.